Astellas Pharma Inc.

Astellas targets urology and oncology with the precision of a parasitoid wasp—identifying specific cellular vulnerabilities, injecting gene therapies that reprogram diseased tissue. Their pipeline focuses on narrow therapeutic niches where specialized interventions beat broad-spectrum approaches.